Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAN1B1 | Q9UKM7 | 2/20 | 0.38 |
| ▸ | FUCA1 | P04066 | 6/20 | 0.33 |
| ▸ | GLA | P06280 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | GBA1 | P04062 | 2/20 | 0.33 |
| ▸ | GLB1 | P16278 | 1/20 | 0.33 |
| ▸ | FUCA2 | Q9BTY2 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | PYGL | P06737 | 1/20 | 0.30 |
| ▸ | AGL | P35573 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18503661 | 1.00 | MAN1B1 (0.38) | MAN1B1FUCA1GLAGAAGBA1 | |
| SCHEMBL9588908 | 1.00 | — | — | |
| SCHEMBL13369627 | 0.91 | — | — | |
| SCHEMBL18892488 | 0.91 | — | — | |
| SCHEMBL2841282 | 0.91 | — | — | |
| Methane SCHEMBL8129203 | 0.86 | — | — | |
| SCHEMBL5798193 | 0.80 | — | — | |
| SCHEMBL13799414 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL27963686 | 0.78 | — | — | |
| SCHEMBL21187266 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994597-B2 | Inorganic siloxane ladder composites and methods of their preparation | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-06-12 | — | — | US | disclosed |
| US-9994597-B2 | Inorganic siloxane ladder composites and methods of their preparation | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170044190-A1 | INORGANIC SILOXANE LADDER COMPOSITES AND METHODS OF THEIR PREPARATION | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-02-16 | — | — | US | disclosed |
| US-20170044190-A1 | INORGANIC SILOXANE LADDER COMPOSITES AND METHODS OF THEIR PREPARATION | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044190-A1 | INORGANIC SILOXANE LADDER COMPOSITES AND METHODS OF THEIR PREPARATION | PCNA, DNMT1, TOP2A | MAN1B1 2674/4885FUCA1 3233/4885GLA 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.